MedMira Inc. (MedMira) announced that it has received the approval from Health Canada for its Reveal Rapid G4 HIV-1/2 Test (Reveal HIV test) for Point-of-Care (POC) use. The Reveal HIV rapid test has ...
Gilead Sciences has battled back from a pipeline disappointment last year to its highest stock price in nearly a decade.
Scientists have been excited about the discovery of HIV-1 broadly neutralizing antibodies ... role in his overly ambitious plans to excise $2 trillion from the federal government's budget as ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the ACACIA study (Antiretrovirals ...
A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the ...
HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today the approval from Health Canada for its Reveal®Rapid G4 HIV-1/2 Test (Reveal® ...
2.1 Whole Blood and Peripheral Blood Mononuclear Cells Typically ... Current approaches highlight that both induction of HIV-1-specific helper cells and coordinated cellular immune response might be ...
The UK government has announced that it is renewing funding for the public health campaign HIV Prevention England for another year as part of efforts to end HIV transmission by 2030. The programme, ...
An overall increase in life expectancy was observed across all individuals living with HIV but disparities between gender groups persist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback